Yoon nominates former boss to head broadcasting watchdog
Korean students outperform OECD average amid pandemic havoc: data
US rejects NK's 'double standard' claim on Seoul's satellite launch
Over 70,000 teens homeless, urgent support needed: professor
6 outgoing ministers ‘strong candidates’ for general elections: ruling party
Genesis golf tournament kicks off in SongdoBy Kim So-hyun
Published : Oct. 6, 2022 - 17:35
A hundred and twenty golfers are competing in the Genesis Championship from Thursday through Sunday at the Jack Nicklaus Golf Club in Songdo, Incheon, for an overall purse of 1.5 billion won ($1.04 million).
With one of the biggest purses on the Korean Tour, the 2022 Genesis Championship is the 19th tournament of this year’s KPGA (Korea Professional Golfers’ Association) season.
The winner will take home 300 million won and a Genesis GV80, along with sponsored exemptions for the Genesis Scottish Open and the Genesis Invitational.
The first player to hit a hole-in-one on the 17th hole will win a GV70 for himself, and a G70 Shooting Brake for his caddie.
This year’s tournament teed off with a gallery for the first time in three years as COVID-19 restrictions have been eased.
Hyundai Motor’s Genesis brand has hosted the Genesis Championship every year since 2017 to serve as a partner to Korean professional golfers who seek to play on the world stage.
Nine Genesis cars will be on display throughout the golf club including recently launched cars such as the G90 and the G70 Shooting Brake. There will also be Genesis cars available as transportation for players on-site throughout the tournament.
Ticket are sold on the Interpark website -- 10,000 won for a one-day pass, 50,000 won for an all-day pass, and 150,000 won for a Genesis Suite one-day pass.
The tournament is broadcast live on the JTBC Golf Channel from 11 a.m. to 5 p.m. on Thursday and Friday, and from 10 a.m. to 4 p.m. on Saturday and Sunday.
Half of young people struggling financially: Seoul
Banks, regulators shift blame for snowballing ELS losses
Drug demand rises over surge in ‘walking pneumonia,’ flu